[P3–166]: NEUROTRANSMITTER‐SPECIFIC METABOLISM IS RELATED TO SEVERITY OF PATHOLOGY AND SYMPTOM EXPRESSION IN ALZHEIMER's DISEASE. (1st July 2017)